CENTURY THERAPEUTICS INC. - COMMON STOCK

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

21 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

09 Nov 2023 06:01:00 By Nasdaq GlobeNewswire

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

09 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer

09 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition

02 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

26 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

09 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

11 May 2023 06:30:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

17 Apr 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Leadership Changes

12 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

16 Mar 2023 06:30:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the AACR Annual Meeting 2023

15 Mar 2023 15:01:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at Upcoming Investor Conferences

21 Feb 2023 06:00:01 By Nasdaq GlobeNewswire

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

08 Feb 2023 06:30:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at Upcoming Investor Conferences

01 Feb 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

05 Jan 2023 15:01:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

22 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

11 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

10 Nov 2022 06:30:01 By Nasdaq GlobeNewswire